Hem › Alpha-1-antitrypsinbrist › Texas
Kliniska studier för Alpha-1-antitrypsinbrist i Texas
4 studier för Alpha-1-antitrypsinbrist söker deltagare vid platser i Texas.
Officiell studietext (engelska)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 11 aug. 2026 · NCT07555483Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Texoma Liver Center, Denison
- Baylor College of Medicine Medical Center, Houston
- The Texas Liver Institute, San Antonio
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 13 maj 2026 · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Texas Liver Institute American Research Corporation, San Antonio
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 5 mars 2026 · NCT06165341A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
- Renovatio Clinical, The Woodlands
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 22 juli 2025 · NCT06049082Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.